- call +1-201-465-4211
- email sales@mrinsights.biz
Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes.
Scope of the Report:
This report focuses on the Influenza Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Influenza Vaccine is expected to grow at a CAGR of roughly 6.7% over the next five years, will reach 4550 million US$ in 2023, from 3090 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
AstraZeneca
CSL
GlaxoSmithKline
Sanofi
Altimmune
BionVax
FluGen
FOLIA BIOTECH
Genentech
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Trivalent
Quadrivalent
Market Segment by Applications, can be divided into
Adults
Pediatrics
There are 15 Chapters to deeply display the global Influenza Vaccine market.
Chapter 1, to describe Influenza Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Influenza Vaccine, with sales, revenue, and price of Influenza Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Influenza Vaccine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Influenza Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Influenza Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Trivalent
1.2.2 Quadrivalent
1.3 Market Analysis by Applications
1.3.1 Adults
1.3.2 Pediatrics
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Influenza Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 CSL
2.2.1 Business Overview
2.2.2 Influenza Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 CSL Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Influenza Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Influenza Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Altimmune
2.5.1 Business Overview
2.5.2 Influenza Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Altimmune Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 BionVax
2.6.1 Business Overview
2.6.2 Influenza Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 BionVax Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 FluGen
2.7.1 Business Overview
2.7.2 Influenza Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 FluGen Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 FOLIA BIOTECH
2.8.1 Business Overview
2.8.2 Influenza Vaccine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 FOLIA BIOTECH Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Genentech
2.9.1 Business Overview
2.9.2 Influenza Vaccine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Genentech Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Influenza Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Influenza Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Influenza Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Influenza Vaccine Manufacturer Market Share in 2017
3.3.2 Top 6 Influenza Vaccine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Influenza Vaccine Market Analysis by Regions
4.1 Global Influenza Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Influenza Vaccine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Influenza Vaccine Revenue and Market Share by Regions (2013-2018)
4.2 North America Influenza Vaccine Sales and Growth Rate (2013-2018)
4.3 Europe Influenza Vaccine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Influenza Vaccine Sales and Growth Rate (2013-2018)
4.5 South America Influenza Vaccine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Influenza Vaccine Sales and Growth Rate (2013-2018)
5 North America Influenza Vaccine by Countries
5.1 North America Influenza Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Influenza Vaccine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Influenza Vaccine Revenue and Market Share by Countries (2013-2018)
5.2 United States Influenza Vaccine Sales and Growth Rate (2013-2018)
5.3 Canada Influenza Vaccine Sales and Growth Rate (2013-2018)
5.4 Mexico Influenza Vaccine Sales and Growth Rate (2013-2018)
6 Europe Influenza Vaccine by Countries
6.1 Europe Influenza Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Influenza Vaccine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Influenza Vaccine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Influenza Vaccine Sales and Growth Rate (2013-2018)
6.3 UK Influenza Vaccine Sales and Growth Rate (2013-2018)
6.4 France Influenza Vaccine Sales and Growth Rate (2013-2018)
6.5 Russia Influenza Vaccine Sales and Growth Rate (2013-2018)
6.6 Italy Influenza Vaccine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Influenza Vaccine by Countries
7.1 Asia-Pacific Influenza Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Influenza Vaccine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Influenza Vaccine Revenue and Market Share by Countries (2013-2018)
7.2 China Influenza Vaccine Sales and Growth Rate (2013-2018)
7.3 Japan Influenza Vaccine Sales and Growth Rate (2013-2018)
7.4 Korea Influenza Vaccine Sales and Growth Rate (2013-2018)
7.5 India Influenza Vaccine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Influenza Vaccine Sales and Growth Rate (2013-2018)
8 South America Influenza Vaccine by Countries
8.1 South America Influenza Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Influenza Vaccine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Influenza Vaccine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Influenza Vaccine Sales and Growth Rate (2013-2018)
8.3 Argentina Influenza Vaccine Sales and Growth Rate (2013-2018)
8.4 Colombia Influenza Vaccine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Influenza Vaccine by Countries
9.1 Middle East and Africa Influenza Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Influenza Vaccine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Influenza Vaccine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Influenza Vaccine Sales and Growth Rate (2013-2018)
9.3 UAE Influenza Vaccine Sales and Growth Rate (2013-2018)
9.4 Egypt Influenza Vaccine Sales and Growth Rate (2013-2018)
9.5 Nigeria Influenza Vaccine Sales and Growth Rate (2013-2018)
9.6 South Africa Influenza Vaccine Sales and Growth Rate (2013-2018)
10 Global Influenza Vaccine Market Segment by Type
10.1 Global Influenza Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Influenza Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Influenza Vaccine Revenue and Market Share by Type (2013-2018)
10.2 Trivalent Sales Growth and Price
10.2.1 Global Trivalent Sales Growth (2013-2018)
10.2.2 Global Trivalent Price (2013-2018)
10.3 Quadrivalent Sales Growth and Price
10.3.1 Global Quadrivalent Sales Growth (2013-2018)
10.3.2 Global Quadrivalent Price (2013-2018)
11 Global Influenza Vaccine Market Segment by Application
11.1 Global Influenza Vaccine Sales Market Share by Application (2013-2018)
11.2 Adults Sales Growth (2013-2018)
11.3 Pediatrics Sales Growth (2013-2018)
12 Influenza Vaccine Market Forecast (2018-2023)
12.1 Global Influenza Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Influenza Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Influenza Vaccine Market Forecast (2018-2023)
12.2.2 Europe Influenza Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Influenza Vaccine Market Forecast (2018-2023)
12.2.4 South America Influenza Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Influenza Vaccine Market Forecast (2018-2023)
12.3 Influenza Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Influenza Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Influenza Vaccine Market Share Forecast by Type (2018-2023)
12.4 Influenza Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Influenza Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Influenza Vaccine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Influenza Vaccine Picture
Table Product Specifications of Influenza Vaccine
Figure Global Sales Market Share of Influenza Vaccine by Types in 2017
Table
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
